Understanding the decision-makers, incentives, and processes that will set the price, access, and funding of a product is a critical step to successfully preparing for a new launch. CRA鈥檚 deep engagement with these issues allows clients to be up to date with the latest developments and likely future changes relevant for their products. This can range from the supranational (e.g., EUnetHTA), national (e.g., German AMNOG reforms), to local (e.g., US Medicare buy-and-bill) dynamics which may limit or drive a product鈥檚 commercial success.